Dr. Mark L. Gordon

Dr. Mark L. Gordon is an internationally recognised physician, lecturer, author, researcher and strategic thinker whose work spans neuroendocrinology, neuroinflammation, traumatic brain injury, hormone optimisation, regenerative medicine and personalised healthcare. His career combines clinical practice, physician education, scientific collaboration and the development of evidence-informed approaches that can be translated into practical healthcare solutions. With more than two decades of international experience, Dr. Gordon has advised physicians, delivered medical education and supported the development of neuroendocrine, regenerative and functional medicine programmes across multiple regions. His international perspective gives him a strong understanding of clinical systems, professional education and the practical application of advanced healthcare models. Dr. Gordon has worked closely with AJT Wellity Asia since its earliest days and has played an important role in shaping the company’s biohacking and medical education direction. He contributes not only as a medical expert, but also as a business-minded strategist who understands how scientific ideas, clinical programmes and healthcare products must be structured to create meaningful value for patients, physicians and organisations. As Chief Medical Innovation Advisor, he helps strengthen the scientific, clinical and commercial foundations of AJT Wellity Asia’s projects. His role includes evaluating medical concepts, guiding programme and protocol development, supporting physician education, contributing to product innovation and identifying opportunities for sustainable healthcare business development. Dr. Gordon is also advancing new healthcare products, clinical protocols and educational solutions that translate science into practical tools for prevention, recovery, health optimisation and long-term wellbeing. His longstanding relationship with AJT Wellity Asia reflects a shared commitment to science, education, responsible innovation and the creation of credible, commercially sustainable healthcare platforms across Asia.